Results 61 to 70 of about 12,790 (151)
Tanaporn Anuntrangsee, Kumutnart Chanprapaph, Wimolsiri Iamsumang Division of Dermatology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, ThailandCorrespondence: Wimolsiri Iamsumang, Division of Dermatology,
Anuntrangsee T +2 more
doaj
Crystal structure of S,N-dibenzyl-d-penicillamine monohydrate
In the asymmetric unit of the title compound, C19H23NO2S·H2O, there are two independent organic molecules and two water molecules. Both organic molecules exist as the zwitterionic form.
Nobuto Yoshinari, Takumi Konno
doaj +1 more source
Introduction: Wilson disease (WD) is a rare metabolic disorder of copper metabolism, requiring life-long therapy, usually with D-penicillamine or trientine. This review compares their clinical effectiveness and safety.
Hafiz Muhammad Ehsan Arshad +5 more
doaj +1 more source
In this work, cytotoxicity and cellular impedance response was compared for CdSe/ZnS core/shell quantum dots (QDs) with positively charged cysteamine–QDs, negatively charged dihydrolipoic acid–QDs and zwitterionic D-penicillamine–QDs exposed to canine ...
Vladimir V. Breus +4 more
doaj +1 more source
WILSON'S DISEASE IN CHILDREN, REPORT OF 25 CASES [PDF]
We conducted a retrospective study of 25 cases (15 boys and 12 girls) of Wilson's disease(Hepatolenticular degeneration)spanning a period of 8 years. Age at the time of diagnosis ranged between 3-17 years. The f ollowing clinical forms were observed:
Y. AGHIGHI, R. AFTENDELIANS
doaj
Nephrotic syndrome after treatment with d-penicillamine in a pediatric patient with Wilson’s disease
We describe a case of nephrotic syndrome (NS) after a 7 months treatment with D-penicillamine in a 14 years old girl with Wilson’s disease , with a prompt regression at the discontinuation of the drug.
M. Farallo +4 more
doaj +1 more source
OBJETIVO: mostrar a evolução de quatro pacientes para remissão clínica completa da esclerose sistêmica (ES), sem necessidade de tratamento medicamentoso atual, após uso de D-penicilamina como medicação principal.
Leandro Antônio Cichoski +3 more
doaj +1 more source
Incidence of Relapse Following Withdrawal Of D-Penicillamine from Combination (D-Penicillamine + Zinc) Therapy in previously symptomatic Hepatic Wilson Disease [PDF]
Kalpana Panda +4 more
openalex +1 more source
Background & Aims: Wilson disease (WD) is caused by accumulation of copper primarily in the liver and brain. During maintenance therapy of WD with D-penicillamine, current guidelines recommend on-treatment ranges of urinary copper excretion (UCE) of ...
Peter Ott +16 more
doaj +1 more source
Evaluation of vitamin B6 supplementation in Wilson's disease patients treated with D-penicillamine. [PDF]
Mbala J +4 more
europepmc +1 more source

